Inovio Pharmaceuticals logo
Inovio Pharmaceuticals INO
€ 3.89 2.39%

Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024

report update icon

Inovio Pharmaceuticals Kennzahlen 2011-2024 | INO

Kennzahlen Jährlich Inovio Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.6 -0.1 -0.2 -10.3 -3.9 -4.8 -4.4 -6.1 -15.6 -13.7 -7.3 -4.4 -4.7

P/S

264.6 2.4 31.8 232.3 111.9 15.3 9.1 12.7 11.2 47.2 36.0 21.2 7.3

EPS

-6.1 -14.1 -17.4 -1.1 -1.2 -1.1 -1.1 -1.0 -0.4 -0.6 -1.4 -0.6 -0.1

EV (Enterprise Value)

259 M 104 M 81.5 M 1.55 B 576 M 487 M 407 M 481 M 436 M 473 M 487 M 92 M 67.9 M

EBITDA per Share

-6.37 -13.3 -17.1 -0.78 -1.07 -0.963 -0.993 -1.01 -0.489 -0.641 -0.422 -0.664 -0.64

EV/EBITDA

-2.2 1.8 -4.9 -5.0 -4.5 -5.8 -11.9 -11.9 -23.2 -3.6 -2.7

PEG

-0.0 -0.0 -0.0 -0.6 -0.25 1.73 -0.63 -0.05 0.53 0.24 -0.05 -0.27 0.16

P/B

1.9 0.1 0.1 3.7 85.1 5.4 2.7 3.6 2.6 4.4 9.2 2.5 1.5

P/CF

-1.8 -0.1 -0.3 -9.7 -4.7 -6.2 -5.3 -6.8 -29.9 -15.8 -31.2 -3.9 -3.6

ROE %

-115.14 -125.84 -75.98 -36.09 -2208.37 -111.42 -61.90 -59.77 -16.59 -32.39 -124.81 -56.43 -31.87

ROA %

-79.04 -80.28 -61.23 -30.83 -82.92 -73.96 -47.11 -42.45 -13.65 -27.41 -74.79 -43.57 -24.96

ROCE %

-122.66 -120.33 -75.37 -26.91 -99.24 -98.20 -55.75 -59.47 -19.35 -33.54 -36.32 -67.04 -44.39

Current Ratio

3.2 2.8 5.2 6.9 2.9 2.5 3.9 2.8 5.5 7.1 2.0 1.9 2.9

DSO

- - 1908.5 474.3 180.4 48.6 56.1 171.0 66.0 97.9 89.5 76.8 18.9

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

- - 1908.5 474.3 - - - - - - - - -

Finanzkreislauf

- - 1908.5 474.3 - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Inovio Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.89 -1.19 -1.31 - -1.52 -1.61 -1.89 - -0.15 -0.46 -0.36 - -0.29 -0.39 -0.27 -0.14 0.12 -0.83 -0.26 -0.38 -0.23 -0.3 -0.3 -0.34 -0.27 -0.07 -0.36 -0.24 -0.39 -0.13 -0.31 -0.35 -0.28 -0.26 -0.11 -0.25 0.08 -0.09 -0.17 -0.12 -0.12 -0.18 -0.2 -0.3 -0.64 -0.24 -0.23 - -0.05 -0.03 -0.06 -0.04 -0.04 -0.02 -0.02

EBITDA per Share

- - -1.33 - - - -2.01 - -0.13 -0.43 -0.32 - -0.28 -0.39 -0.26 -0.16 -0.21 -0.2 -0.2 -0.3 -0.21 -0.27 -0.28 -0.3 -0.26 -0.04 -0.35 -0.25 -0.32 -0.11 -0.29 -0.3 -0.26 -0.24 -0.21 -0.2 0.06 -0.22 -0.13 -0.18 -0.13 -0.16 -0.18 -0.15 0.02 -0.12 -0.17 -0.04 -0.05 -0.05 -0.03 -0.04 -0.05 -0.04 -0.04

ROE %

-124.37 -114.70 -102.36 -65.94 -80.11 -69.72 -85.19 -72.89 -86.15 -85.25 -64.95 -38.77 -44.05 -26.63 -38.38 -36.09 -1127.20 -1803.55 -2631.14 -3474.70 -2416.22 -1772.80 -924.94 -111.54 -88.73 -83.92 -82.94 -61.95 -68.12 -60.99 -69.50 -59.81 -48.75 -28.73 -17.11 -16.61 -13.06 -22.70 -28.77 -32.48 -55.27 -107.69 -118.75 -125.88 -98.33 -58.74 -50.08 -57.25 -66.91 -57.23 -51.17 -32.24 -9.60 -5.96 -5.10

ROA %

-88.77 -82.84 -73.99 -48.07 -57.71 -49.78 -58.14 -51.01 -62.24 -63.83 -54.09 -33.42 -37.93 -23.14 -33.11 -30.83 -52.48 -72.08 -68.65 -82.92 -81.89 -84.93 -69.58 -73.96 -60.30 -59.45 -59.45 -47.11 -50.72 -44.45 -50.15 -42.45 -35.74 -21.18 -13.33 -13.65 -10.88 -18.94 -24.15 -27.41 -39.29 -68.82 -72.98 -74.79 -58.74 -38.44 -35.30 -43.57 -51.08 -43.84 -39.30 -24.96 -7.43 -4.62 -3.95

ROCE %

-130.57 -119.12 -106.67 -69.67 -83.07 -70.75 -83.86 -68.59 -81.81 -81.62 -63.00 -38.61 -44.98 -39.64 -30.47 -26.91 -906.14 -1595.53 -2409.29 -3234.51 -2382.85 -1716.23 -901.25 -108.23 -90.37 -80.22 -81.00 -58.74 -60.81 -56.69 -64.71 -61.84 -51.97 -33.46 -27.28 -19.51 -21.15 -30.76 -31.28 -35.51 -40.87 -31.92 -33.60 -37.26 -40.13 -59.90 -68.85 -68.39 -62.47 -57.55 -48.65 -45.73 -13.39 -10.86 -9.27

Current Ratio

3.2 3.6 3.7 3.2 3.5 3.7 4.0 2.8 3.1 2.8 4.9 5.2 6.5 7.1 8.9 6.9 6.9 6.9 6.9 1.0 1.0 1.0 1.0 3.0 3.0 3.0 3.0 4.2 4.2 4.2 4.2 3.5 3.5 3.5 3.5 5.6 5.6 5.6 5.6 6.5 6.5 6.5 6.5 2.5 2.5 2.5 2.5 4.4 4.4 4.4 4.4 4.6 4.6 4.6 4.6

DSO

- 1958.2 - - - - 704.6 - 34.5 493.6 2170.5 - 2799.6 3853.1 1688.7 1818.8 1888.7 1586.7 2109.5 108.7 100.2 84.6 292.9 120.9 535.6 583.6 278.0 62.3 207.1 26.8 96.0 169.6 115.1 232.7 130.1 112.5 27.7 126.6 89.5 104.1 139.0 67.3 118.2 173.2 31.8 383.5 129.6 66.8 88.7 173.8 35.0 26.1 16.2 17.6 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- 1958.2 - - - - 704.6 - 34.5 493.6 2170.5 - 2799.6 3853.1 1688.7 1818.8 1888.7 1586.7 2109.5 108.7 100.2 84.6 292.9 120.9 535.6 583.6 278.0 62.3 207.1 26.8 96.0 169.6 115.1 232.7 130.1 112.5 27.7 126.6 89.5 104.1 139.0 67.3 118.2 173.2 31.8 383.5 129.6 66.8 88.7 173.8 35.0 26.1 16.2 17.6 -

Finanzkreislauf

- 1958.2 - - - - 704.6 - 34.5 493.6 2170.5 - 2799.6 3853.1 1688.7 1818.8 1888.7 1586.7 2109.5 108.7 100.2 84.6 292.9 120.9 535.6 583.6 278.0 62.3 207.1 26.8 96.0 169.6 115.1 232.7 130.1 112.5 27.7 126.6 89.5 104.1 139.0 67.3 118.2 173.2 31.8 383.5 129.6 66.8 88.7 173.8 35.0 26.1 16.2 17.6 -

Alle Zahlen in USD-Währung